ProText Mobility, Inc. (OTCPK:TXTM) acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. (OTCPK:PLPL) for $0.12 million on March 27, 2017. Under the terms of the transaction, Protext acquired 100% of the capital stock of Cannabis Biosciences in exchange for 50 million shares of its common stock and subsequently Cannabis Biosciences became a wholly owned subsidiary of ProText Mobility, Inc. (OTCPK:TXTM).

ProText Mobility, Inc. (OTCPK:TXTM) completed the acquisition of Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. (OTCPK:PLPL) on March 27, 2017.